YOYamillie Ortiz

Yamillie Ortiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yamillie Ortiz has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hyperoxia and iron homeostasis in developing human airway smooth muscle

    by Yamillie Ortiz, Maunick Lefin Koloko Ngassie, Colleen M. Bartman, Christina M. Pabelick, Y. S. Prakash

    Recognizing that antioxidant systems are impaired in the airways of premature infants, we used human fetal airway cells to explore the impact of oxygen on iron regulation and iron-mediated cell death (ferroptosis). We find moderate hyperoxia impairs antioxidant systems that prevent ferroptosis and dysregulates iron metabolism, while severe hyperoxia has a negative effect on mechanisms driving the early onset of ferroptosis. Inhibitors of ferroptosis decrease iron and lipid peroxidation, demonstrating links between oxygen and iron regulation in developing airways.

  • Open Access

    Dysregulated Iron Metabolism In Remodeling of Aging Asthmatic Human Airways

    by Maunick Lefin Koloko Ngassie, Yamillie Ortiz, Preetham Ravi, Daniel A. Pfeffer-Kleemann, Samantha K. Hamrick, Michael A. Thompson, Yun Hua Fang, Christina M. Pabelick, Y. S. Prakash

    Iron is essential for cellular function, and lung cells are no exception. Previous studies have demonstrated an association between increased level of iron in the lung and aging and age-related lung diseases including pulmonary fibrosis and asthma in the elderly (AIE). However, the mechanisms underlying the accumulation of iron with aging or AIE, or the cell types involved, remain understudied. In the context of asthma, airway smooth muscle is a key cell type contributing to contractility as well as airway remodeling (proliferation, fibrosis). In this study we characterized iron level and regulation in human (hASM) from young (2+ ) were determined using the fluorescent dye FerroOrange. Cell lysates were analyzed for iron accumulation, antioxidant, lipid peroxidation, and extracellular matrix (ECM) markers, and cell proliferation was assessed. We found that iron accumulates with aging, but surprisingly decreases with AIE. hASM from AIE patients showed activated antioxidant pathways and lipid peroxidation, while FAC-exposure impaired iron metabolism and enhanced ECM deposition. Iron depletion mitigated the antioxidant response, lipid peroxidation, cell proliferation, ECM production. These findings suggest that iron metabolism in hASM contributes to cell hyperplasia and ECM, while in aging and particularly AIE, counter-regulatory changes in iron metabolism and antioxidant pathways occur, overall promoting airway remodeling.

  • The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases

    by Maunick Lefin Koloko Ngassie, Yamillie Ortiz, Preetham Ravi, Daniel A. Pfeffer-Kleemann, Niyati Borkar, Christina Pabelick, Y.S. Prakash

    Iron is an important metal element regulating biological processes such as gene expression, electron transport, cell proliferation, differentiation and division, and cellular respiration. Regulation of iron levels is therefore critical, with excess iron accumulation leading to iron-dependent lipid peroxidation and cell death (ferroptosis). Factors such as aging and environmental exposures (e.g. high/low oxygen, particulate iron) can disrupt iron homeostasis. Iron-dependent processes influence downstream pathways such as inflammation, mitochondrial energetics, and remodeling (proliferation, fibrosis): pathways involved in lung diseases particularly at the extremes of age: from hyperoxic lung injury in neonates to chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis (PF) that increase with age. While these diseases involve structural and functional changes in bronchial vs. alveolar compartments, including airway hyperreactivity, altered mucus production, cell proliferation and migration, increased extracellular matrix (ECM) remodeling, senescence and metabolic dysregulation, the casual or consequential links between iron dysregulation and disease pathology, particularly with aging, are still being investigated. The aim of this topical review is to (i) highlight current knowledge regarding iron regulation in normal lung vs. lung diseases, (ii) identify known roles of iron in lung homeostasis, and the contribution of iron dysregulation in lung diseases with aging, and (iii) explore the potential benefit of targeting iron regulation and/or ferroptosis in lung diseases.